Skip to main content

Abbott Laboratories (NYSE: ABT) Investor Securities Class Action Lawsuit 08/31/2022

  • If you purchased shares of Abbott Laboratories (NYSE: ABT), you have certain options. NYSE: ABT investors should contact the Shareholders Foundation, Inc.

  • To have your information reviewed for options and to receive notifications about this case, please send an email to mail@shareholdersfoundation.com, or call us at (858) 779-1554.

Site Members can sign up for company wide alerts

Lawsuit Overview

August 21, 2026 - A motion for preliminary approval of a settlement in the amount of $88.5 million was filed. July 25, 2026 - The case was dismissed but gave the plaintiffs leave to amend. April 21, 2023 - An amended complaint was filed. August 31, 2022 - An investor in shares of Abbott Laboratories (NYSE: ABT) filed a lawsuit in the U.S. District Court for the Northern District of Il...



You must register (for free) or login to view the entire case.